Filters

Hiroshi Nakatsumi, Yoshito Komatsu, Satoshi Yuki, Susumu Sogabe, Miki Tateyama, Shuichi Muto, Mineo Kudo, Kanji Kato, Takuto Miyagishima, Minoru Uebayashi, Takashi Meguro, Koji Oba, Masahiro Asaka

Chemotherapy 2013;58(6):439-44

Full Text

Abstract

Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.

Alexandra Selby, Zachary Wilmer Reichenbach, Gregory Piech, Frank K Friedenberg

Digestive diseases and sciences 2020;64(12):3385-3393

Full Text

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Serotonin 5-HT3 Receptor Antagonists""[mesh_terms]

5-HT3 receptors.

Treatment of irritable bowel syndrome.

Functional diarrhea.

Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis.

Irritable bowel syndrome.

Management of cisplatin-associated toxicities in bladder cancer patients.

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.

Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.

Memantine in neurological disorders - schizophrenia and depression.

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.

Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea.

Results for

""Serotonin 5-HT3 Receptor Antagonists""[mesh_terms]